Lv64
2680 积分 2023-03-12 加入
Discovery of Potent and Selective BCL6 Ligand-Directed Degrader (LDD), BCL6-760
1天前
已完结
Synthetic lethality in cancer drug discovery: challenges and opportunities
12天前
已完结
Translational Research on the Oral Delivery of the Cytotoxic PROTAC Molecule via Tumor-Targeting Prodrug Strategy for Triple-Negative Breast Cancer Treatment
13天前
已完结
Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human Kinome
1个月前
已完结
Structure-Based Design and Optimization of Methionine Adenosyltransferase 2A (MAT2A) Inhibitors with High Selectivity, Brain Penetration, and In Vivo Efficacy
1个月前
已完结
Drug Metabolism and Pharmacokinetics
2个月前
已完结
Development of a Series of Pyrrolopyridone MAT2A Inhibitors
2个月前
已完结
Overview of Methionine Adenosyltransferase 2A (MAT2A) as an Anticancer Target: Structure, Function, and Inhibitors
2个月前
已完结
Discovery of 2(1H)-Quinoxalinone Derivatives as Potent and Selective MAT2A Inhibitors for the Treatment of MTAP-Deficient Cancers
2个月前
已完结
Discovery of Novel Spirocyclic MAT2A Inhibitors Demonstrating High In Vivo Efficacy in MTAP-Null Xenograft Models
2个月前
已完结
皖公网安备34019202002308
